The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Sep. 14, 2010
Filed:
May. 21, 2007
Aya Jakobovits, Beverly Hills, CA (US);
Arthur B. Raitano, Los Angeles, CA (US);
Daniel E. H. Afar, Brisbane, CA (US);
Douglas Saffran, Encinitas, CA (US);
Rene S. Hubert, Los Angeles, CA (US);
Mary Faris, Los Angeles, CA (US);
Pia M. Challita-eid, Encino, CA (US);
Aya Jakobovits, Beverly Hills, CA (US);
Arthur B. Raitano, Los Angeles, CA (US);
Daniel E. H. Afar, Brisbane, CA (US);
Douglas Saffran, Encinitas, CA (US);
Rene S. Hubert, Los Angeles, CA (US);
Mary Faris, Los Angeles, CA (US);
Pia M. Challita-Eid, Encino, CA (US);
Agensys, Inc., Santa Monica, CA (US);
Abstract
A novel gene (designated 101P3A11 or PHOR-1) and its encoded protein, and variants thereof, are described wherein 101P3A11 exhibits tissue specific expression in normal adult tissue, and is aberrantly expressed in the cancers listed in Table I. Consequently, 101P3A11 provides a diagnostic, prognostic, prophylactic and/or therapeutic target for cancer. The 101P3A11 gene or fragment thereof, or its encoded protein, or variants thereof, or a fragment thereof, can be used to elicit a humoral or cellular immune response; antibodies or T cells reactive with 101P3A11 can be used in active or passive immunization.